New research has found that children with disorders on the autism spectrum have lower physical activity levels and worse sleep in comparison to their peers. One of the study’s coauthors, Xiao Liang, stated that the study was driven by results from earlier research as well as his experience as an inclusive education teacher in Hong Kong.
Liang, who is a research assistant professor in the rehabilitation sciences department at Hong Kong Polytechnic University, added that he discovered that students with autism spectrum disorders (ASD) had low levels of physical activity during class as well as recess and lunch break.
For his previous research, he carried out a systematic review to summarize accelerometer-measured levels of physical activity in adolescents and children with ASD. He determined that only 47% of adolescents and children with ASD met the WHO-recommended guidelines on physical activity guidelines and noted that age-related reductions in physical activity were evident in adolescents and children around the globe.
For the latest study, Liang and his colleagues systematically reviewed 28 observational studies that evaluated differences in sleep parameters or levels of physical activity between adolescents and children with and without ASD. Of the total number of participants included in the review, 1,573 participants had no ASD while 805 were on the spectrum. All were between 5 and 16 years of age.
Once the review was done, the researchers calculated the effect sizes to represent the differences in sleep parameters and levels of physical activity levels between adolescents and children with and without ASD. Lastly, the researchers explored the moderating effect of age on the differences in levels of physical activity between both groups using meta-regression.
They discovered that in comparison to their peers, adolescents and children with ASD had longer time in sleep latency, lower sleep efficiency, lower total time for sleep and lower levels of physical activity. The researchers hope that pediatricians and primary care providers can encourage children and adolescents to meet daily physical activity guidelines as recommended by the WHO to maintain their health.
The researchers add that physical activity intervention should also be used to improve sleep and problematic areas as well as executive function in adolescents and children with ASD.
In the report, Lian noted that he hoped the research encouraged more studies on tailored physical activity interventions to help young ones with ASD to improve their sleep and other functions. Further, he asserted that his team remained dedicated to working toward good mental and physical health through physical activity interventions. The study’s findings were reported in “JAMA Network Open.”
A number of companies such as PaxMedica Inc. (NASDAQ: PXMD) are working to develop novel treatments for various neurologic conditions, including autism spectrum disorder. The success of these efforts will benefit plenty of affected people around the world.
NOTE TO INVESTORS: The latest news and updates relating to PaxMedica Inc. (NASDAQ: PXMD) are available in the company’s newsroom at https://ibn.fm/PXMD
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed)and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN